Latest From the
world of Reformulary

Meet the Experts: Tumour Agnostic Therapies with Dr. Bill Evans

Canada has two systems for cannabis use, but they’re at risk of blending into one

Cannabis Standard Insights, Issue #3 published by Reformulary Group

Reformulary Group announces partnership with Data Fabric platform Cinchy

Reformulary Group announces pilot of productivity tool for cannabis and other medicines

Reformulary Group launches drug coverage exception process

Cannabis Standard Index brings much-needed clarity to medical cannabis

Reformulary Group announces preferred pharmacy partnership with Rexall

Reformulary Group launches Quality of Life tool for prescription drugs and cannabis

Reformulary Group joins BlackNorth Initiative to combat anti-black racism in Canadian business

Reformulary Group Announces Partnership with VIVO Cannabis

Reformulary Group launches COVID-19 DEW Report